These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 25145789)

  • 21. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
    Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
    Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphological assessment of pancreatic islet hormone content following aerobic exercise training in rats with poorly controlled Type 1 diabetes mellitus.
    McDonald MW; Murray MR; Hall KE; Noble EG; Melling CW
    Islets; 2014; 6(2):e29221. PubMed ID: 25483959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-fat-diet-induced remission of diabetes in a subset of K
    Yan Z; Shyr ZA; Fortunato M; Welscher A; Alisio M; Martino M; Finck BN; Conway H; Remedi MS
    Diabetes Obes Metab; 2018 Nov; 20(11):2574-2584. PubMed ID: 29896801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolbutamide controls glucagon release from mouse islets differently than glucose: involvement of K(ATP) channels from both α-cells and δ-cells.
    Cheng-Xue R; Gómez-Ruiz A; Antoine N; Noël LA; Chae HY; Ravier MA; Chimienti F; Schuit FC; Gilon P
    Diabetes; 2013 May; 62(5):1612-22. PubMed ID: 23382449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defects in beta cell Ca²+ signalling, glucose metabolism and insulin secretion in a murine model of K(ATP) channel-induced neonatal diabetes mellitus.
    Benninger RK; Remedi MS; Head WS; Ustione A; Piston DW; Nichols CG
    Diabetologia; 2011 May; 54(5):1087-97. PubMed ID: 21271337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of the mutation "diabetes" on insulin release and islet morphology in mice of different genetic backgrounds.
    Boquist L; Hellman B; Lernmark A; Täljedal IB
    J Cell Biol; 1974 Jul; 62(1):77-89. PubMed ID: 4135113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Functional and Metabolomic Consequences of K
    Li C; Ackermann AM; Boodhansingh KE; Bhatti TR; Liu C; Schug J; Doliba N; Han B; Cosgrove KE; Banerjee I; Matschinsky FM; Nissim I; Kaestner KH; Naji A; Adzick NS; Dunne MJ; Stanley CA; De León DD
    Diabetes; 2017 Jul; 66(7):1901-1913. PubMed ID: 28442472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-1 beta inhibits phospholipase C and insulin secretion at sites apart from KATP channel.
    Vadakekalam J; Rabaglia ME; Metz SA
    Am J Physiol; 1997 Nov; 273(5):E942-50. PubMed ID: 9374680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes.
    Leibowitz G; Yuli M; Donath MY; Nesher R; Melloul D; Cerasi E; Gross DJ; Kaiser N
    Diabetes; 2001 Feb; 50 Suppl 1():S113-7. PubMed ID: 11272167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural nucleotide analogs are potent activators/inhibitors of pancreatic β cell KATP channels: an emerging mechanism supporting their use as antidiabetic drugs.
    Tricarico D; Rolland JF; Cannone G; Mele A; Cippone V; Laghezza A; Carbonara G; Fracchiolla G; Tortorella P; Loiodice F; Conte Camerino D
    J Pharmacol Exp Ther; 2012 Feb; 340(2):266-76. PubMed ID: 22028392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute sulfonylurea therapy at disease onset can cause permanent remission of KATP-induced diabetes.
    Remedi MS; Agapova SE; Vyas AK; Hruz PW; Nichols CG
    Diabetes; 2011 Oct; 60(10):2515-22. PubMed ID: 21813803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluating insulin secretagogues in a humanized mouse model with functional human islets.
    Luo J; Nguyen K; Chen M; Tran T; Hao J; Tian B; Rulifson IC; Zhang Y; Tian L; Zhang Y; Lopez E; Lin DC; Wang Y; Ma Z; Houze J; Guo Z
    Metabolism; 2013 Jan; 62(1):90-9. PubMed ID: 22982177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A functional circadian clock is required for proper insulin secretion by human pancreatic islet cells.
    Saini C; Petrenko V; Pulimeno P; Giovannoni L; Berney T; Hebrok M; Howald C; Dermitzakis ET; Dibner C
    Diabetes Obes Metab; 2016 Apr; 18(4):355-65. PubMed ID: 26662378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Steamed Ginger May Enhance Insulin Secretion through K
    Nam YH; Hong BN; Rodriguez I; Park MS; Jeong SY; Lee YG; Shim JH; Yasmin T; Kim NW; Koo YT; Lee SH; Paik DH; Jeong YJ; Jeon H; Kang SC; Baek NI; Kang TH
    Nutrients; 2020 Jan; 12(2):. PubMed ID: 31991895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beta-cell mass depletion precedes the onset of hyperglycaemia in the GK rat, a genetic model of non-insulin-dependent diabetes mellitus.
    Movassat J; Saulnier C; Portha B
    Diabete Metab; 1995 Dec; 21(5):365-70. PubMed ID: 8586154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Critical role of gap junction coupled KATP channel activity for regulated insulin secretion.
    Rocheleau JV; Remedi MS; Granada B; Head WS; Koster JC; Nichols CG; Piston DW
    PLoS Biol; 2006 Feb; 4(2):e26. PubMed ID: 16402858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperglycemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background.
    Korsgren O; Jansson L; Sandler S; Andersson A
    J Clin Invest; 1990 Dec; 86(6):2161-8. PubMed ID: 2254465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-cell specific deletion of Dicer1 leads to defective insulin secretion and diabetes mellitus.
    Kalis M; Bolmeson C; Esguerra JL; Gupta S; Edlund A; Tormo-Badia N; Speidel D; Holmberg D; Mayans S; Khoo NK; Wendt A; Eliasson L; Cilio CM
    PLoS One; 2011; 6(12):e29166. PubMed ID: 22216196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine.
    Doliba NM; Qin W; Vatamaniuk MZ; Li C; Zelent D; Najafi H; Buettger CW; Collins HW; Carr RD; Magnuson MA; Matschinsky FM
    Am J Physiol Endocrinol Metab; 2004 May; 286(5):E834-43. PubMed ID: 14736703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paradoxical reduction in pancreatic glucagon with normalization of somatostatin and decrease in insulin in normoglycemic alloxan-diabetic dogs: a putative mechanism of glucagon irresponsiveness to hypoglycemia.
    Rastogi KS; Lickley L; Jokay M; Efendic S; Vranic M
    Endocrinology; 1990 Feb; 126(2):1096-104. PubMed ID: 1967577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.